UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010689
Receipt number R000012495
Scientific Title Effect of etidronate therapy on prevention of fracture, bone mineral density and bone turnover markers in osteoporotic patients with severe motor and intellectual disabilities: a randomized controlled trial
Date of disclosure of the study information 2013/05/10
Last modified on 2013/05/10 16:01:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of etidronate therapy on prevention of fracture, bone mineral density and bone turnover markers in osteoporotic patients with severe motor and intellectual disabilities: a randomized controlled trial

Acronym

EOSMID

Scientific Title

Effect of etidronate therapy on prevention of fracture, bone mineral density and bone turnover markers in osteoporotic patients with severe motor and intellectual disabilities: a randomized controlled trial

Scientific Title:Acronym

EOSMID

Region

Japan


Condition

Condition

osteoporosis

Classification by specialty

Medicine in general Endocrinology and Metabolism Geriatrics
Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Occurrence of fragile fracture, bone mineral density and bone turnover markers (serum TRAP-5b, serum NTX, serum BAP) are evaluated for oral administration of etidronate versus non-administered controls in osteoporotic patients with severe motor and intellectual disabilities. This is a randomized, open-label, multicenter trial.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

occurrence of fragile fracture

Key secondary outcomes

changes of bone mineral density (L2-4) and bone turnover markers (serum TRAP-5b, serum NTX, serum BAP)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients without history of fragile fracture for the past 5 years.
Repeated administration of etidronate (200mg) for 2 weeks, following a cessation for 10 weeks.

Interventions/Control_2

Patients without history of fragile fracture for the past 5 years.
Ordinary treatment.

Interventions/Control_3

Patients with history of fragile fracture for the past 5 years.
Repeated administration of etidronate (200mg) for 2 weeks, following a cessation for 10 weeks.

Interventions/Control_4

Patients with history of fragile fracture for the past 5 years.
Ordinary treatment.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with osteoporosis (BMD: less than 70% of YAM)
2. Patients with severe motor and intellectual disabilities (Ohshima's classification: 1,2,3,4)
3. Patients with informed of consent obtained from a parent or other family member.

Key exclusion criteria

1. Patients with other diseases presenting low BMD
2. Patients with GERD

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigenori Yamamoto

Organization

NHO Shimoshizu National Hospital

Division name

Pediatrics

Zip code


Address

Chiba Yotsukaido Shikawatashi 934-5

TEL

043-422-2511

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shigenori Yamamoto

Organization

NHO Shimoshizu National Hospital

Division name

Pediatrics

Zip code


Address

Chiba, Yotsukaido, Shikawatashi 934-5

TEL

043-422-2511

Homepage URL

http://www.hosp.go.jp/~simosizu/

Email

syamamoto3@nifty.com


Sponsor or person

Institute

National Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構下志津病院(千葉県)、国立病院機構愛媛病院(愛媛県)、国立病院機構柳井医療センター(山口県)、国立病院機構青森病院(青森県)、国立病院機構岩手病院(岩手県)、国立病院機構南京都病院(京都府)、国立病院機構高知病院(高知県)、国立病院機構西別府病院(大分県)、国立病院機構千葉東病院(千葉県)、国立病院機構宮崎病院(宮崎県)、国立病院機構香川小児病院(香川県)、国立病院機構医王病院(石川県)、国立病院機構新潟病院(新潟県)、国立病院機構山口宇部医療センター(山口県)、国立病院機構西群馬病院(群馬県)、国立病院機構広島西医療センター(広島県)、国立病院機構名古屋医療センター(愛知県)


Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 10 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 12 Month 03 Day

Date of IRB


Anticipated trial start date

2010 Year 01 Month 04 Day

Last follow-up date

2014 Year 03 Month 31 Day

Date of closure to data entry

2014 Year 03 Month 31 Day

Date trial data considered complete

2014 Year 03 Month 31 Day

Date analysis concluded

2014 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 05 Month 10 Day

Last modified on

2013 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012495


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name